Research Article

Construction and Comprehensive Analyses of a Competing Endogenous RNA Network in Tumor-Node-Metastasis Stage I Hepatocellular Carcinoma

Table 1

Clinical characteristics of the included patients.

CharacteristicsNumber of sample size, n = 171 (%) (mRNA, lncRNA)Number of sample size, n = 172 (%) (miRNA)

Age (years)
 ≥6095 (55.56)95 (55.23)
 <6076 (44.44)77 (44.77)

Gender
 Female50 (29.24)49 (28.49)
 Male121 (70.76)123 (71.51)

Family history
 Yes52 (30.41)51 (29.65)
 No119 (69.59)121 (70.35)

Race
 White78 (45.61)77 (44.77)
 Asian81 (47.37)81 (47.09)
 Black or african american8 (4.68)8 (4.65)
 NA4 (2.34)6 (3.49)

Tumor status
 With tumor44 (25.73)46 (26.74)
 Tumor free117 (68.42)116 (67.44)
 NA10 (5.85)10 (5.81)

Hepatitis B virus infection
 Yes69 (40.35)70 (40.70)
 No96 (56.14)96 (55.81)
 NA6 (3.51)6 (3.49)

Histologic grade
 Grade 125 (14.62)25 (14.53)
 Grade 280 (46.78)80 (46.51)
 Grade 355 (32.16)56 (32.56)
 Grade 410 (5.85)11 (6.40)
 NA1 (0.58)0 (0.00)

Vascular invasion
 Macro5 (2.92)5 (2.91)
 Micro17 (9.94)18 (10.47)
 None137 (80.12)138 (80.23)
 NA12 (7.02)11 (6.40)

Residual tumor
 R0154 (90.06)155 (90.12)
 R15 (2.92)5 (2.91)
 R20 (0.00)0 (0.00)
 RX9 (5.26)9 (5.23)
 NA3 (1.75)3 (1.74)

Vital status
 Living129 (75.44)131 (76.16)
 Deceased42 (24.56)41 (23.84)

Relapse
 Yes62 (36.26)65 (37.79)
 No88 (51.46)88 (51.16)
 NA21 (12.28)19 (11.05)